CRISPR Nucleic Acid Detection: Visual Strip Readout or Pure CRISPR Assay
At the beginning of a CRISPR nucleic acid detection project, the most important distinction is between a visual strip readout and a pure CRISPR detection system. Both can support rapid testing, but their acceptance goals, sensitivity limits, material checklists and collaboration boundaries are different.
Two project positions
The first route combines CRISPR nucleic acid technology with immunochromatographic or colloidal-gold lateral-flow visualization. Its value is simple on-site operation, intuitive two-line visual reading and strong scenario adaptability.
The second route is a pure CRISPR nucleic acid detection system. The final result is not handed over to a gold strip for naked-eye interpretation, so it is more suitable for low-abundance targets, ultra-low concentration samples and projects where sensitivity is the primary goal.
Why visual reading and ultra-high sensitivity should not be mixed casually
In a visual strip project, the final result is limited by the lateral-flow visualization end. Even if CRISPR is used upstream, whether a line can be seen still depends on colloidal gold or label-capture visibility, membrane background, color intensity and visual threshold.
If the sample target concentration is not very low, and the project values field screening or simple operation, such as certain species-origin identification or sample-rich scenarios, the visual strip route can be practical.
If the project involves blood-borne viruses, very low viral load, post-treatment low-abundance targets or samples that are easy to miss by conventional nucleic acid testing, a pure CRISPR assay or an instrument-read system should be evaluated first.
Four items to clarify before starting
First, primer and probe design. Nucleic acid assay success depends heavily on target sequence strategy, primers and probes. This should be confirmed by a team or service provider with nucleic acid design experience. JY Biotech is better suited to supporting downstream strip materials, lateral-flow structure and project matching.
Second, enzyme and reaction-system selection. CRISPR projects may involve Cas12, Cas13, Cas9 or other routes, and the supplier should be selected according to target, readout method, reaction temperature, lyophilization need and cost target.
Third, reaction device or use format. The project should clarify whether it is only laboratory method verification, a custom reaction device from scratch, or a portable and commercial product for field use and mass production.
Fourth, sample pretreatment and extraction. Mature extraction or pretreatment routes can often be used first, then validated according to sample type, cost per test, package format and on-site workflow.
Cost and collaboration boundaries
Common early-stage costs include primer/probe design and preparation, enzyme system or lyophilized bead preparation, reaction device or consumable customization, sample pretreatment reagents and strip-material validation.
If a visual strip route is selected, NC membrane, release pad, absorbent pad, backing card, label-capture chemistry, running buffer and cassette packaging should be included in the checklist. If a pure CRISPR route is selected, more attention should be given to reaction chemistry, signal output, instrument or portable reader, temperature control and stability.
Where JY Biotech can support
Shanghai JY Biotechnology has served the rapid diagnostic industry for 18 years and can support discussions around immunochromatographic strips, colloidal gold, Ahlstrom diagnostic materials, membranes and pads, backing cards, cassettes, release pads, absorbent pads and material adoption.
For CRISPR visual-strip projects, customers are advised to clarify sample type, target concentration range, sensitivity requirement, naked-eye reading need, available primers/probes and enzyme system before entering strip-material validation.
FAQ
When is a CRISPR visual strip suitable?
It is suitable when the target concentration is not extremely low, sample volume is sufficient, on-site reading is valuable and the acceptance goal is not ultimate sensitivity.
Are low-abundance viral samples suitable for visual strips?
They require caution. If target load is very low, the naked-eye strip end may become the sensitivity limit. Pure CRISPR or instrument-read routes should be evaluated first.
Does JY Biotech design primers?
The website positions primer, probe and target-sequence strategy as independent key tasks that should be confirmed by the customer team or a specialized service provider. JY Biotech is better suited to strip materials, lateral-flow structure and downstream matching.
What information helps consultation?
Sample type, target, concentration range, application scenario, naked-eye reading requirement, available primers/probes, enzyme system, readout method and commercialization plan are helpful.
RELATED